UBS AM’s Climb Bio CLYM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.74K Buy
+413
New +$5.76K ﹤0.01% 3916

Other funds holding CLYM

UBS AM's CLYM Position: Q3 2026 in Review

UBS AM opened a new position in Climb Bio (CLYM) in Q3 2026: 413 shares worth $4.74K. The stake represents ﹤0.01% of the portfolio and ranks #3916 among its holdings.

112 funds tracked by Wall St. Rank hold CLYM as of Q3 2026.

  • UBS AM held 413 shares of Climb Bio worth $4.74K as of Q3 2026.
  • Climb Bio was a new UBS AM position in Q3 2026.
  • Climb Bio made up ﹤0.01% of UBS AM's portfolio in Q3 2026, its #3916 holding.
  • 112 funds tracked by Wall St. Rank held Climb Bio as of Q3 2026.

Based on UBS AM's 13F filing for Q3 2026, filed 16 Nov 2026.